European Disease Progression Monitor: Edition 4

COVID-19 disease progression monitor

EU Disease-progression-review

Italy, Spain and France past COVID-19 peak

Germany and U.K. later peaks than EU

latest death rate in EU

EU5 past COVID-19 peak intensity

COVID-19 treatments and preventative therapies

disease progression monitor disclaimer

For more information, please visit lek.com/covid19 or fill out this form to get in touch.

Other editions in this series:
European Disease progression monitor: Edition III

Related Insights

Life Sciences & Pharma

The Race to Lead in Life Sciences Innovation: Lessons from Global Benchmarks

December 30, 2025

Contract/Pharma Services

Indonesia’s Clinical Trial Ecosystem: From Potential to Performance

November 25, 2025

Life Sciences & Pharma

On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (Australia)

November 11, 2025

Life Sciences & Pharma

Unlocking Growth: Singapore's Role in Advancing Life Sciences and Medtech Innovations

March 10, 2025

Private Equity

Future Ready: Comprehensive Operational Due Diligence on a Medtech and Life Sciences…

February 24, 2025

A private equity firm approached L.E.K. Consulting to conduct operational due diligence on a promising precision medtech and life sciences engineering…

Executive Insights

Life Sciences & Pharma

Aligning Aseptic Fill/Finish Operations With Global Pharmaceutical Demand

February 3, 2025